IndicaRx is a Boston-based, end-to-end Contract Research Organization (CRO) built by scientists, for scientists. We specialize in neuromuscular, cardiac, and rare disease drug development, providing fully integrated preclinical solutions that bridge the gap between discovery and IND.

Founded by a team with decades of experience in academic research and biotech R&D, IndicaRx was created to solve a critical market gap: early-stage biotech companies are expected to navigate complex, high-stakes science with limited resources and fragmented support. We change that.

At IndicaRx, we combine deep disease area expertise, custom assay development, and regulatory-ready execution into one seamless service. Our model is flexible—offering both fee-for-service and equity-for-service partnerships—and built to align with the realities of early-stage innovation.

We don’t just run studies. We co-develop programs with our partners, providing the insight, execution, and strategic clarity needed to secure funding, meet regulatory milestones, and ultimately get life-changing therapies to patients.

Science is the engine. Partnership is the fuel. Let's build together.